Tissue mechanics promote IDH1-dependent HIF1α–tenascin C feedback to regulate glioblastoma aggression

References 46

1. 1.

   Brat DJ, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372:2481-2498.

   Not in our library10.1056/nejmoa1402121

2. 2.

   Yan H, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360:765-773.

   Not in our library10.1056/nejmoa0808710

3. 3.

   Van den Bent MJ, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol. 2013;31:344-350.

   Not in our library10.1200/jco.2012.43.2229

4. 4.

   Cairncross G, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013;31:337-343.

   Not in our library10.1200/jco.2012.43.2674

5. 5.

   Losman JAJA, Kaelin WG. What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 2013;27:836-852.

   Not in our library10.1101/gad.217406.113

6. 6.

   Zhao S, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1. Science. 2009;324:261-265.

   Not in our library10.1126/science.1170944

7. 7.

   Koivunen P, et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature. 2012;483:484-488.

   Not in our library10.1038/nature10898

8. 8.

   Levental KR, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139:891-906.

   Not in our library10.1016/j.cell.2009.10.027

9. 9.

   Mouw JK, et al. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat Med. 2014;20:360-367.

   Not in our library10.1038/nm.3497

10. 10.

    Kumar S, Weaver VM. Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev. 2009;28:113-127.

    Not in our library10.1007/s10555-008-9173-4

11. 11.

    Lopez JI, Kang I, You WK, McDonald DM, Weaver VM. In situ force mapping of mammary gland transformation. Integr Biol (Camb). 2011;3:910-921.

    Not in our library10.1039/c1ib00043h

12. 12.

    Geiss GK, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26:317-325.

    Not in our library10.1038/nbt1385

13. 13.

    Colman H, et al. A multigene predictor of outcome in glioblastoma. Neuro-Oncol. 2010;12:49-57.

    Not in our library10.1093/neuonc/nop007

14. 14.

    Ruoslahti E. Brain extracellular matrix. Glycobiology. 1996;6:489-492.

    Not in our library10.1093/glycob/6.5.489

15. 15.

    Wade A, et al. Proteoglycans and their roles in brain cancer. FEBS J. 2013;280:2399-2417.

    Not in our library10.1111/febs.12109

16. 16.

    Zimmermann DR, Dours-Zimmermann MT. Extracellular matrix of the central nervous system: from neglect to challenge. Histochem Cell Biol. 2008;130:635-653.

    Not in our library10.1007/s00418-008-0485-9

17. 17.

    Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061-1068.

    Not in our library10.1038/nature07385

18. 18.

    Brennan CW, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155:462-477.

    Not in our library10.1016/j.cell.2013.09.034

19. 19.
    Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways · 2014

    No notice
20. 20.

    Koperek O, Akin E, Asari R, Niederle B, Neuhold N. Expression of hypoxia-inducible factor 1 α in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis. Virchows Arch. 2013;463:795-802.

    Not in our library10.1007/s00428-013-1484-3

21. 21.

    Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009;3:287-310.

    Not in our library10.1007/s12079-009-0075-1

22. 22.

    Turcan S, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 2012;483:479-483.

    Not in our library10.1038/nature10866

23. 23.

    Chesnelong C, et al. Lactate dehydrogenase A silencing in IDH mutant gliomas. Neuro-Oncol. 2014;16:686-695.

    Not in our library10.1093/neuonc/not243

24. 24.

    Tarhonskaya H, et al. Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases. Nat Commun. 2014;5:3423.

    Not in our library10.1038/ncomms4423

25. 25.

    Wierenga ATJ, Vellenga E, Schuringa JJ. Convergence of hypoxia and TGFβ pathways on cell cycle regulation in human hematopoietic stem/progenitor cells. PLoS ONE. 2014;9:e93494.

    Not in our library10.1371/journal.pone.0093494

26. 26.

    Marucci G, et al. Pathological spectrum in recurrences of glioblastoma multiforme. Pathologica. 2015;107:1-8.

    Not in our library

27. 27.

    Li R, et al. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution. Oncotarget. 2015;6:7318-7324.

    Not in our library10.18632/oncotarget.3440

28. 28.

    Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 2000;60:1254-1260.

    Not in our library

29. 29.

    Paszek MJ, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8:241-254.

    Not in our library10.1016/j.ccr.2005.08.010

30. 30.

    Miroshnikova YA, et al. Engineering strategies to recapitulate epithelial morphogenesis within synthetic three-dimensional extracellular matrix with tunable mechanical properties. Phys Biol. 2011;8:026013.

    Not in our library10.1088/1478-3975/8/2/026013

31. 31.
    Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health · 2011

    No notice
32. 32.

    Chang JH, et al. MicroRNA-203 modulates the radiation sensitivity of human malignant glioma cells. Int J Radiat Oncol Biol Phys. 2016;94:412-420.

    Not in our library10.1016/j.ijrobp.2015.10.001

33. 33.

    Liao H, et al. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Oncotarget. 2015;6:8914-8928.

    Not in our library10.18632/oncotarget.3563

34. 34.

    Le LTN, et al. Loss of miR-203 regulates cell shape and matrix adhesion through ROBO1/Rac/FAK in response to stiffness. J Cell Biol. 2016;212:707-719.

    Not in our library10.1083/jcb.201507054

35. 35.

    Scherr M, et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res. 2007;35:e149.

    Not in our library10.1093/nar/gkm971

36. 36.

    Williams SC, et al. R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma. Acta Neuropathol. 2011;121:279-281.

    Not in our library10.1007/s00401-010-0790-y

37. 37.

    Xu W, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011;19:17-30.

    Not in our library10.1016/j.ccr.2010.12.014

38. 38.

    Noushmehr H. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 2010;17:510-522.

    Not in our library10.1016/j.ccr.2010.03.017

39. 39.

    Evans SM, et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res. 2004;10:8177-8184.

    Not in our library10.1158/1078-0432.ccr-04-1081

40. 40.

    Vordermark D. Significance of hypoxia in malignant glioma. Re: Evans et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res. 2004;10:8177-84.

    Not in our library10.1158/1078-0432.ccr-04-1081

41. 41.

    Lu KV, et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 2012;22:21-35.

    Not in our library10.1016/j.ccr.2012.05.037

42. 42.

    Johnson KR, Leight JL, Weaver VM. Demystifying the effects of a three-dimensional microenvironment in tissue morphogenesis. Methods Cell Biol. 2007;83:547-583.

    Not in our library10.1016/s0091-679x(07)83023-8

43. 43.

    Sarkaria JN, et al. Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin Cancer Res. 2006;12:2264-2271.

    Not in our library10.1158/1078-0432.ccr-05-2510

44. 44.
    Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine · 2013

    No notice
45. 45.

    Kriegel AJ, Liang M. MicroRNA in situ hybridization for formalin fixed kidney tissues. J Vis Exp. 2013;81:50785.

    Not in our library10.3791/50785

46. 46.

    Lakins JN, Chin AR, Weaver VM. Exploring the link between human embryonic stem cell organization and fate using tension-calibrated extracellular matrix functionalized polyacrylamide gels. Methods Mol Biol. 2012;916:317-350.

    Not in our library10.1007/978-1-61779-980-8_24

Cited by papers we hold 8

• Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives · 2024
  No notice
• The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis · 2023
  No notice
• The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications · 2022
  Not checked
• Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors · 2022
  No notice
• Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin · 2018
  Not checked
• Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier · 2018
  No notice
• Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids · 2017
  No notice
• The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.